SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Purchased by Cerity Partners LLC

Cerity Partners LLC raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.8% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,605 shares of the exchange traded fund’s stock after buying an additional 1,016 shares during the quarter. Cerity Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $1,509,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. Alliancebernstein L.P. purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $607,000. Golden State Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after purchasing an additional 319 shares in the last quarter. Dynamic Advisor Solutions LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $825,000. O Shaughnessy Asset Management LLC raised its position in SPDR S&P Biotech ETF by 38.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after purchasing an additional 200 shares in the last quarter. Finally, Concurrent Investment Advisors LLC raised its position in SPDR S&P Biotech ETF by 3.7% in the 1st quarter. Concurrent Investment Advisors LLC now owns 8,504 shares of the exchange traded fund’s stock valued at $690,000 after purchasing an additional 300 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $85.87 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The firm has a market capitalization of $4.69 billion, a PE ratio of 11.47 and a beta of 0.97. The stock’s 50-day simple moving average is $82.78 and its 200-day simple moving average is $84.46.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.